Search research articles
Contact Us
Filters
Showing results (31-40 of 203) with videos related to
Page
of 21
Sort By:
Molecular Medicine Reports
|
June 12, 2015
Anti-tumor peptide AP25 decreases cyclin D1 expression and inhibits MGC-803 proliferation via phospho-extracellular signal-regulated kinase-, Src-, c-Jun N-terminal kinase- and phosphoinositide 3-kinase-associated pathways
Jialiang Hu, Tao Cheng, Lijun Zhang, et al.
Medicine
|
May 11, 2017
Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer: A meta-analysis
Xi Sun, Guangyan Zhangyuan, Liang Shi, et al.
Frontiers in Oncology
|
September 23, 2021
A New Clinical Nomogram From the TCGA Database to Predict the Prognosis of Hepatocellular Carcinoma
Dingde Ye, Jiamu Qu, Jian Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 6, 2024
DCAF1 interacts with PARD3 to promote hepatocellular carcinoma progression and metastasis by activating the Akt signaling pathway
Jinyao Zhang, Yuze Shi, Ke Ding, et al.
Molecular Medicine Reports
|
July 3, 2026
[Retracted] Anti‑tumor peptide AP25 decreases cyclin D1 expression and inhibits MGC‑803 proliferation via phospho-extracellular signal‑regulated kinase‑, Src‑, c‑Jun N‑terminal kinase‑ and phosphoinositide 3--kinase‑associated pathways
Jialiang Hu, Tao Cheng, Lijun Zhang, et al.
Endocrine Research
|
January 26, 2005
Telomerase is not required for experimental tumorigenesis of human and bovine adrenocortical cells
Meizhen Chen, Christina L Hawks, Qin Huang, et al.
Journal of Hepatocellular Carcinoma
|
October 11, 2022
Circular RNA circRASSF5 Functions as an Anti-Oncogenic Factor in Hepatocellular Carcinoma by Acting as a Competitive Endogenous RNA Through Sponging miR-331-3p
Zhao Zhou, Xiaohan Cui, Peng Gao, et al.
Oncotarget
|
February 26, 2015
Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma
Junwei Tang, Runqiu Jiang, Lei Deng, et al.
Cell Cycle (Georgetown, Tex.)
|
April 17, 2008
The level of oncogene H-Ras correlates with tumorigenicity and malignancy
Beicheng Sun, Yun Gao, Lei Deng, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
January 16, 2024
NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1
Zhiheng Zhang, Bojiao Song, Haowei Wei, et al.
Page
of 21
Search research articles
Search
Showing results (31-40 of 203) with videos related to
Sort By:
Page
of 21
Molecular Medicine Reports
|
June 12, 2015
Anti-tumor peptide AP25 decreases cyclin D1 expression and inhibits MGC-803 proliferation via phospho-extracellular signal-regulated kinase-, Src-, c-Jun N-terminal kinase- and phosphoinositide 3-kinase-associated pathways
Jialiang Hu, Tao Cheng, Lijun Zhang, et al.
Medicine
|
May 11, 2017
Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer: A meta-analysis
Xi Sun, Guangyan Zhangyuan, Liang Shi, et al.
Frontiers in Oncology
|
September 23, 2021
A New Clinical Nomogram From the TCGA Database to Predict the Prognosis of Hepatocellular Carcinoma
Dingde Ye, Jiamu Qu, Jian Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 6, 2024
DCAF1 interacts with PARD3 to promote hepatocellular carcinoma progression and metastasis by activating the Akt signaling pathway
Jinyao Zhang, Yuze Shi, Ke Ding, et al.
Molecular Medicine Reports
|
July 3, 2026
[Retracted] Anti‑tumor peptide AP25 decreases cyclin D1 expression and inhibits MGC‑803 proliferation via phospho-extracellular signal‑regulated kinase‑, Src‑, c‑Jun N‑terminal kinase‑ and phosphoinositide 3--kinase‑associated pathways
Jialiang Hu, Tao Cheng, Lijun Zhang, et al.
Endocrine Research
|
January 26, 2005
Telomerase is not required for experimental tumorigenesis of human and bovine adrenocortical cells
Meizhen Chen, Christina L Hawks, Qin Huang, et al.
Journal of Hepatocellular Carcinoma
|
October 11, 2022
Circular RNA circRASSF5 Functions as an Anti-Oncogenic Factor in Hepatocellular Carcinoma by Acting as a Competitive Endogenous RNA Through Sponging miR-331-3p
Zhao Zhou, Xiaohan Cui, Peng Gao, et al.
Oncotarget
|
February 26, 2015
Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma
Junwei Tang, Runqiu Jiang, Lei Deng, et al.
Cell Cycle (Georgetown, Tex.)
|
April 17, 2008
The level of oncogene H-Ras correlates with tumorigenicity and malignancy
Beicheng Sun, Yun Gao, Lei Deng, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
January 16, 2024
NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1
Zhiheng Zhang, Bojiao Song, Haowei Wei, et al.
Page
of 21